Search
for
Did you mean Upper Respiratory Infections?
Research 10 of 1000+
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Baricitinib for the Treatment of Alopecia Areata
- Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Adverse effects of baricitinib in comparison to methotrexate in the treatment of severe alopecia areata
- EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →